Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G for SUTRO BIOPHARMA, INC. Common Stock, $0.001 par value (STRO).
- Disclosed ownership: 7.6%.
- Date of event: 10 Feb 2026.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 7.6% ownership in SUTRO BIOPHARMA, INC. Common Stock, $0.001 par value (STRO) on 10 Feb 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 4.1% | 668,693 | 0 | 668,693 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 4.1% | 668,693 | 0 | 668,693 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3% | 488,916 | 0 | 488,916 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3% | 488,916 | 0 | 488,916 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.5% | 75,359 | 0 | 75,359 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.5% | 75,359 | 0 | 75,359 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 7% | 1,157,609 | 0 | 1,157,609 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 7.6% | 1,251,788 | 0 | 1,251,788 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 7.6% | 1,251,788 | 0 | 1,251,788 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 7.6% | 1,251,788 | 0 | 1,251,788 | /s/ Mark N. Lampert | Mark N. Lampert |